Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,600 across all filing types
Latest filing 2024-10-09 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
113年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (杏輝) providing information about fund lending balances and endorsement guarantees for the current and previous months, including cumulative amounts and limits. The content is brief (624 characters) and consists mainly of tabular data about financial guarantees and endorsements, without detailed financial statements or management discussion. It does not present a full financial report, earnings release, or management commentary. It is a regulatory disclosure of financial guarantee information, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-10-09 Chinese
113年9月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝 for the period of September 2024 (民國113年09月). It includes comparative figures from the previous year and percentage changes. The document is short (773 characters) and primarily presents financial summary data without detailed financial statements or analysis. It does not contain a full annual or interim report, nor does it appear to be an earnings release or management discussion. It is a brief financial summary report, which aligns best with the Fund Information / Factsheet (FS) category, as it provides key financial facts in a concise format.
2024-10-09 Chinese
113年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, senior management, and their related parties. It lists share types, holdings at appointment, monthly changes, and current holdings. This type of disclosure is typical of insider share transactions or holdings disclosures. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification.
2024-10-07 Chinese
113年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and initial holdings, pledged shares, and related party holdings. It is a report on insider shareholdings and changes, typical of disclosures about personal share transactions or holdings by company insiders. There is no indication of financial results, management discussion, or other report types. The document length is 3506 characters, which is relatively short and focused on insider shareholding data. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2024-10-07 Chinese
113年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (杏輝) providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabulated data on financial guarantees and limits but does not include comprehensive financial statements or detailed analysis. The document length is only 624 characters, indicating it is a short regulatory disclosure rather than a full report. There is no indication of an annual or interim report, audit report, or earnings release. The content fits the profile of a regulatory filing providing specific financial information disclosures without being a full report or announcement of a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-09-10 Chinese
113年8月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, with comparisons to the previous year. It includes percentage changes and notes on accounting standards (IFRS) application. The document length is short (772 characters) and it primarily provides a brief financial summary without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement of a report publication. It is a brief financial summary report, which aligns best with the Fund Information / Factsheet (FS) category, as it provides key financial facts in a concise format.
2024-09-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.